Education
About Us
Working with TipRanks
Follow Us
Cibus (CBUS)
NASDAQ:CBUS
Earnings Data
Report Date
May 07, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.22Last Year’s EPS
-1.34Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed substantial positive progress on technology performance, regulatory milestones, customer engagements, and near-term commercialization plans (especially for rice and sustainable ingredients). Management also executed meaningful cost reductions and secured a $22.3M financing to extend runway. Major challenges remain: the company is still loss-making with a Q4 net loss widened ~23.6%, royalty interest expense is significant, collaboration revenue timing weighed on results, and cash runway extends only into late 2026 absent further revenue or financing. Overall, the call emphasized execution and upcoming catalysts (EU plenary vote, Interox definitive agreement, Latin America field results) that support momentum but also highlighted the need to convert progress into cash flow in the near term.Company Guidance
Strong Commercial Momentum in Rice (RISE)
Seven RISE customers represent over $200 million in potential annual royalty opportunity; initial market entry targeted in Latin America in 2027, U.S. expansion in 2028, and India/Asia closer to 2030. Management is targeting 5–7 million acres in the Americas as initial scale.
Regulatory Progress and Market Access
Key regulatory wins include EU political agreement on new genomic techniques (plenary vote expected in late April 2026), UK PBO framework live (first PBO filings submitted in Jan 2026), 17 positive USDA APHIS determinations, California authorization for gene-edited rice planting, Ecuador and Peru confirmation of equivalence to conventional breeding — collectively accelerating commercial conversations globally.
Technology Performance Improvements
Rice editing efficiency improved by an 'order of magnitude' in 2025 (~10x), enabling faster, more predictable edits (12–15 month cycle to return elite germplasm). Platform progress across multiple crops (canola HT2 positive field results, sclerotinia resistance, pod-shatter trials, wheat single-cell regeneration, improved soybean editing rates) increases partnership optionality.
First Sustainable Ingredients Revenue and Commercialization Path
Received first customer payment from the sustainable ingredients (biofragrance) program and reported an initial commercial sale; company is formalizing an expanded partnership and targeting commercial-scale production as a near-term revenue stream.
Partnerships and Commercial Frameworks
Entered a non-binding LOI with Interox (framework to commercialize herbicides on rice in Ecuador and Colombia in 2027) and signed agreements with regional seed partners (e.g., Semiano, Semias del Hula). Selected by UK DEFRA-funded consortium as gene editing technology partner for light leaf spot resistance in oilseed rape.
Cash Raise and Cost Reductions Extend Runway
Raised $22.3 million in gross proceeds from a public offering in January 2026. Cash and cash equivalents were $9.9 million at 12/31/2025; management expects existing cash plus recent measures to fund operations into late 2026. Company reduced operating expenses by approximately $10 million for full year 2025.
CBUS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CBUS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 17, 2026 | $3.68 | $2.77 | -24.73% |
Nov 13, 2025 | $1.25 | $1.22 | -2.40% |
Aug 14, 2025 | $1.47 | $1.41 | -4.08% |
May 08, 2025 | $2.35 | $2.14 | -8.94% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Cibus (CBUS) report earnings?
Cibus (CBUS) is schdueled to report earning on May 07, 2026, After Close (Confirmed).
What is Cibus (CBUS) earnings time?
Cibus (CBUS) earnings time is at May 07, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CBUS EPS forecast?
CBUS EPS forecast for the fiscal quarter 2026 (Q1) is -0.22.